PBAC to consider three lymphoma drugs
- Hodgkin lymphoma
- Non-Hodgkin lymphoma
- Treatments and side-effects
Tag: Hodgkin lymphoma
Expert Series: AProf. Michael Dickinson discusses CAR T-cell therapy
Associate Professor Michael Dickinson says CAR T-cell therapy is a 'revolutionary step forward'.
- Acute lymphoblastic leukaemia
- Chronic lymphocytic leukaemia
- Hodgkin lymphoma
- Interviews with experts
- Myeloma
- Non-Hodgkin lymphoma
- Research
- Treatments and side-effects
Blood cancer and other people’s positivity
Sam was in denial about her lymphoma diagnosis, but struggled with how people related to her after her diagnosis.
- Hodgkin lymphoma
- Lifestyle and living well
Expert Series: Q&A with Professor Judith Trotman on lymphoma
We had an in-depth chat with the Head of Haematology at Concord Repatriation General Hospital in Sydney about her career highlights, lymphoma research news and how her international collaborative group, Women in Lymohonma is instigating change.
- Hodgkin lymphoma
- Interviews with experts
- Research
I took control after becoming adrift in the system
The long wait for a diagnosis took its toll on Bronwyn Bisley, but her biggest challenges lay ahead as the information she desperately needed dried up.
- Hodgkin lymphoma
New research breakthroughs
Researchers such Dr Siok Tey are dedicated to driving rapid advancements in treatments, discovering new therapies, and launching innovative clinical trials.
- Hodgkin lymphoma
- Research
Providing a home full of heart
The Nield family were overwhelmed by the care provided by the Leukaemia Foundation while their seven-year-old son Hodgkin lymphoma.
- Hodgkin lymphoma
- Support services
Leukaemia Foundation invests $2.8m in innovative lymphoma research
Better understanding and treatment of lymphoma is the focus of eight new research projects that are part of the Leukaemia Foundation’s National Research Program.
- Hodgkin lymphoma
- Non-Hodgkin lymphoma
- Research
Unlocking the key to understanding cell death 
PhD student Elizabeth is investigating how mutations in a tumour suppressor protein, known as p53, contribute to the development of lymphoma.
- Hodgkin lymphoma
- Non-Hodgkin lymphoma
- Research
Bronwyn advocated for when and where she was treated
By the time Bronwyn Bisley was finally given a diagnosis she already knew.
- Hodgkin lymphoma
- “Live life to the fullest”: Josh Gourlay opens up about returning to work and new beginnings after blood cancer
- Advocacy news – July 2024
- Talking Blood Cancer: Estate planning and medical directives
- Running for a Cause: Cal Gates’ Journey from Newcastle to Sydney on foot in one weekend
- World Blood Cancer Day 2024